scholarly journals Regulating for Bias in Medical Education – Reaction to the Pharmaceutical Industry Updated EFPIA Code of Practice

2019 ◽  
Vol 8 (1) ◽  
pp. 1685771 ◽  
Author(s):  
Marcin Rodzinka ◽  
Annabel Seebohm ◽  
Eugene Pozniak ◽  
Lina Mosch ◽  
Lara De Luca ◽  
...  
Keyword(s):  
Medical Education ◽  
Pharmaceutical Industry ◽  
Code Of Practice

CME and the Pharmaceutical Industry: Towards a More Ethical Relationship

2002 ◽  
Vol 10 (2) ◽  
pp. 108-110
Author(s):  
Julian Freidin ◽  
Nigel Prior ◽  
Grant Sara
Keyword(s):  
Medical Education ◽  
Pharmaceutical Industry ◽  
Patient Care ◽  
Continuing Medical Education ◽  
General Council ◽  
Complex Nature ◽  
The Public ◽  
The Relationship

Objectives: To feedback the strategies put to, and accepted by, General Council as a result of the survey of College Fellows views on the ethics of the relationship between the Pharmaceutical Industry and Continuing Medical Education (CME). Conclusions: The proposals accepted by General Council recognise that education of registrars and psychiatrists about the complex nature of their relationships with Industry, increasing their awareness of how this may impact on patient care and encouraging greater individual and collective openness are important steps to take in increasing the confidence of the public that we genuinely are their advocates in all matters to do with the Pharmaceutical Industry.

Corporate Disguises in Medical Science

2011 ◽  
Vol 31 (6) ◽  
pp. 482-492 ◽  
Author(s):  
Sergio Sismondo
Keyword(s):  
Medical Education ◽  
Pharmaceutical Industry ◽  
Medical Research ◽  
Continuing Medical Education ◽  
Medical Science ◽  
Opinion Leaders ◽  
Key Opinion Leaders ◽  
Research And Education ◽  
Approved Drugs ◽  
Education Courses

Roughly 40% of the sizeable medical research and literature on recently approved drugs is “ghost managed” by the pharmaceutical industry and its agents. Research is performed and articles are written by companies and their agents, though apparently independent academics serve as authors on the publications. Similarly, the industry hires academic scientists, termed key opinion leaders, to serve as its speakers and to deliver its continuing medical education courses. In the ghost management of knowledge, and its dissemination through key opinion leaders, we see the pharmaceutical industry attempting to hide or disguise the interests behind its research and education.

Sign in / Sign up

Export Citation Format

Share Document